Krishna
Founder, ShylCare
A pharmacist at a mid-sized hospital in Maharashtra once told me something that stuck: "I don't dispense medicines. I decode handwriting." He was only half joking. His daily job involved interpreting handwritten prescriptions where the difference between Losartan and Lisinopril was a single ambiguous loop in the doctor's cursive.
Medication errors are one of the most common patient safety problems worldwide, and India is no exception. Studies published in Indian journals have reported medication error rates ranging from 5% to as high as 30% depending on the setting and how errors are defined. Most of these never cause serious harm. But some do. And nearly all of them are preventable.
When you trace medication errors back to their source, a pattern emerges. It's not usually a doctor who doesn't know pharmacology. It's a system that creates gaps between what the doctor intended and what the patient receives.
Illegible handwriting. This is the classic one, and it's real. A busy OPD doctor writes 40–60 prescriptions in a session. By patient thirty, the handwriting deteriorates. Drug names, dosages, and frequency become progressively harder to read. The pharmacist guesses. Usually they guess right. Sometimes they don't.
mg vs ml confusion. This is more common than hospitals admit. A doctor writes "5ml" when they mean "5mg" — or vice versa. For oral syrups in paediatrics, this distinction matters enormously. A handwritten "m" followed by an ambiguous letter has caused dosing errors that could have been caught by any system that distinguishes between the two.
Drug interactions missed. A patient is on warfarin from their cardiologist. They visit a GP for joint pain, and the GP prescribes a painkiller that interacts with warfarin. Neither doctor checks the other's prescription because they don't have access to it. The patient is now at risk for a bleeding event. This isn't rare — it happens constantly in a healthcare system where patients see multiple doctors who don't share records.
Allergies not flagged. Patient tells the doctor they're allergic to sulfa drugs. Doctor notes it — maybe — but the prescription contains a sulfa-based antibiotic. Nobody catches it because the allergy information isn't linked to the prescription system. It's a note on a paper file that nobody reads during a busy OPD.
Pharmacy interpretation. Even when the prescription is legible, the pharmacist is interpreting it. "Tab Azithromycin 500mg OD x 3d" seems clear — but which brand? What if they have two brands in stock? Does the pharmacist check with the doctor? Usually not. They pick what's available. This works most of the time, but it introduces a layer of human judgment where a direct electronic link would be better.
I want to be specific here because "digital prescriptions" can mean anything from a typed PDF to a fully integrated system. The meaningful improvements come from integration, not just typing.
Searchable drug database. Instead of writing a drug name from memory, the doctor selects from a database. No ambiguity. No spelling errors. The pharmacist receives "Amlodipine 5mg" — not a squiggle that could be Amlodipine or Amitriptyline. This is the single biggest safety improvement and it's embarrassingly simple.
Auto dose suggestions. When the doctor selects a drug, the system can suggest standard dosing — typical adult dose, paediatric dose by weight, maximum daily dose. The doctor still chooses, but they have a reference point. This catches the "wait, is the adult dose 500mg or 250mg?" hesitations that happen in a fast OPD.
Drug interaction checking. When the prescription is electronic and the patient's medication history is in the system, every new prescription can be checked against existing medications automatically. Doctor prescribes a fluoroquinolone for a patient already on theophylline — the system flags it before the prescription reaches the pharmacy. This works in real time, at the point of prescribing, which is the only point where intervention is practical.
Allergy flags. If the patient's allergy is recorded in their profile, the system can block or warn when a contraindicated drug is prescribed. This requires the allergy to actually be entered — which is a workflow problem, not a technology problem — but once it's there, the safety net is automatic.
Pharmacy receives an exact order. This is the integration piece. In a paper system, the pharmacist reads a prescription and interprets it. In an integrated system, the pharmacist receives a digital order with the exact drug, exact dosage, exact quantity, exact frequency. There's nothing to interpret. The dispensing queue shows exactly what needs to go out. This eliminates an entire category of error.
I'm not going to pretend that switching to digital prescriptions eliminates all medication errors. It doesn't. Doctors can still select the wrong drug from a dropdown — though this is harder than writing the wrong name. Patients can still not disclose allergies. The database has to be maintained with current drug information.
But the shift from interpretation to information transfer — from a pharmacist decoding handwriting to a pharmacist filling an exact electronic order — is a genuine safety improvement. It removes ambiguity from a process where ambiguity is dangerous.
The objection I hear from doctors is always the same: "This will slow me down."
It's a fair concern. If the digital prescription workflow is slower than scribbling on a pad, doctors won't use it, safety benefits or not.
This is a software design problem, not a fundamental limitation. In ShylCare, the prescription workflow uses templates, favourites, and auto-populated regimens so that a routine prescription takes fewer keystrokes than writing it by hand. The drug search is fast — type three letters, select, done. For a doctor who sees the same conditions repeatedly, templates make the process faster, not slower.
The safety features are invisible to the doctor during normal use. They only surface when something is actually wrong — an interaction, an allergy, an unusual dose. That's the right design: don't slow down the normal case, catch the dangerous case.
Want to see this in action? Book a demo.
We'll walk through your actual workflows — no generic demo, no slide deck.